Nobilis Therapeutics Announces FDA Clearance of IND to Commence Phase...

Nobilis Therapeutics, a biopharmaceutical company today announced that the U.S. Food & Drug Administration (FDA) has allowed it to initiate a Phase 2b clinical trial of its lead drug candidate...(PRWeb July 21, 2020)Read the full story at https://www.prweb.com/releases/nobilis_therapeutics_announces_fda_clearance_of_ind_to_commence_phase_2b_trial_of_nbtx_001_inhaler_for_treatment_of_panic_disorder/prweb17268079.htm
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Source Type: news